State of Wyoming’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
+80,262
New +$346K 0.05% 402
2024
Q1
Sell
-7,542
Closed -$49.4K 1756
2023
Q4
$49.4K Buy
7,542
+1,222
+19% +$7.89K 0.01% 1306
2023
Q3
$63.2K Sell
6,320
-3,987
-39% -$43.8K 0.01% 1157
2023
Q2
$128K Buy
10,307
+4,189
+68% +$56.5K 0.04% 664
2023
Q1
$85.7K Buy
+6,118
New +$87.9K 0.03% 862
2022
Q2
Sell
-1,093
Closed -$39K 2043
2022
Q1
$39K Buy
+1,093
New +$36.6K 0.02% 1190
2021
Q4
Sell
-2,733
Closed -$134K 1940
2021
Q3
$134K Sell
2,733
-67
-2% -$3.27K 0.09% 306
2021
Q2
$117K Buy
+2,800
New +$109K 0.07% 389

Other funds holding MRVI

State of Wyoming's MRVI Position: Q2 2026 in Review

State of Wyoming opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 80,262 shares worth $501K. The stake represents 0.05% of the portfolio and ranks #402 among its holdings. This is a return to the name: State of Wyoming previously reported a position in MRVI as recently as Q4 2023.

State of Wyoming first reported a position in MRVI in Q2 2021 and has held it in 8 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • State of Wyoming held 80,262 shares of Maravai LifeSciences worth $501K as of Q2 2026.
  • Maravai LifeSciences was a new State of Wyoming position in Q2 2026.
  • Maravai LifeSciences made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #402 holding.
  • State of Wyoming first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 8 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.